Skip to main navigation Skip to search Skip to main content

The insulin-sensitizing effect of rosiglitazone in type 2 diabetes mellitus patients does not require improved in vivo muscle mitochondrial function

  • V.B. Schrauwen-Hindeling
  • , M. Mensink
  • , M.K.C. Hesselink
  • , J.-P. Sels
  • , M.E. Kooi
  • , P. Schrauwen

    Research output: Contribution to journal › Article › Academic › peer-review

    Original languageEnglish
    Pages (from-to)2917-2921
    JournalJournal of Clinical Endocrinology and Metabolism
    Volume93
    Issue number7
    DOIs
    Publication statusPublished - 2008

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Cite this